Express.co.uk |
DIABETES TREATMENT OPERATION TRADES HANDS
U-T San Diego Bristol-Myers Squibb, which bought Amylin Pharmaceuticals, a San Diego-based drugmaker, last year, is selling its entire diabetes business to partner AstraZeneca for up to $4.3 billion. AstraZeneca will pay $2.7 billion upfront and up to $1.4 billion … Astra's Diabetes Shot Won't Cure Growth ProblemsWall Street Journal AstraZeneca to Acquire Bristol Stake in Diabetes VentureBusinessweek AstraZeneca seals diabetes drug dealExpress.co.uk Fox Business –RTT News all 221 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.